American Journal of Managed Care—December 21, 2016
American Journal of Managed Care interviews Allan Gibofsky, MD, rheumatologist at HSS, to discuss the need for individualized treatments especially in rheumatology. He explains some current challenges in the field and what developments he'd like to see in the future.
"I think among the more significant challenges are the ability to predict who will do well and who will not," said Dr. Gibofsky. "We haven't yet evolved to the stage where we have credible and reliable biomarkers to allow us to individualize therapy - perhaps someday we will. But for now, despite our guidelines and recommendations, we're still acting empirically in the choice of therapies."
This interview originally appeared at AJMC.com.